Tech Company Inital Public Offerings
RAPT Therapeutics IPO
RAPT Therapeutics was acquired by . Shares were listed on 10/30/2019.
Transaction Overview
Company Name
Announced On
10/30/2019
Transaction Type
IPO
Amount
$36,000,000
Proceeds Purpose
Per the firm's latest filing, it plans to use the net proceeds from the IPO as follows: approximately $20.0 million to $25.0 million to fund the development of FLX475 beyond PoC results from our Phase 1/2 clinical trial; approximately $20.0 million to $25.0 million to fund the development of RPT193 beyond our Phase 1 trial in healthy volunteers and patients with AD; and the remaining proceeds for continued development of an RPT-GCN2i or other future drug candidate, continued refinement of our proprietary drug discovery and development engine, hiring of additional personnel, capital expenditures, costs of operating as a public company and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
561 Eccles Ave.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
We changed our name to RAPT Therapeutics (formerly FLX Bio) (Nasdaq: RAPT) to more accurately represent the company's unrelenting determination and passionate drive to leverage our expertise in immunology, small molecule drug discovery and computational biology to conquer cancer and allergic inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Wong
Chief Medical Officer
William Ho
Vice President
Dirk Brockstedt
Vice President
Paul Kassner
Vice President
David Wustrow
Browse more venture capital transactions:
Prev: 10/30/2019: ElasticRun venture capital transaction
Next: 10/30/2019: Burst Oral Care venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs